Ruxandra C. Marin

Virtual screening of substances used in the treatment of SARS-CoV-2 infection and analysis of compounds with known action on structurally similar proteins from other viruses

T. Behl, S. Bungău, A. F. Bungau, 2022, Biomedicine & Pharmacotherapy.

Efficiency of antiviral treatment in COVID-19.

T. Behl, F. Bǎnicǎ, S. Bungău, 2021, Experimental and therapeutic medicine.

Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat

T. Behl, S. Bungău, N. Negrut, 2021, Biomedicines.

Comparison of Tolerability and Impact on Metabolic Profiles of Antiretroviral Regimens Containing Darunavir/Ritonavir or Darunavir/Cobicistat in Romanian HIV Infected Patients

A. Streinu-Cercel, S. Bungău, O. Săndulescu, 2021, Biomedicines.

Immune recovery among Romanian HIV/AIDS patients receiving darunavir/ritonavir or darunavir/cobicistat regimens in cART management: A three-year study.

S. Bungău, A. Radu, R. Moleriu, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Analysis of virological response to therapy and resistance profile in treatment-experienced and naive HIV-1 infected Romanian patients receiving regimens containing darunavir boosted with ritonavir or cobicistat.

A. Streinu-Cercel, S. Bungău, L. Moleriu, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.